BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33320454)

  • 1. COVID-19 and obesity: the meeting of two pandemics.
    Brandão SCS; Godoi ETAM; de Oliveira Cordeiro LH; Bezerra CS; de Oliveira Xavier Ramos J; de Arruda GFA; Lins EM
    Arch Endocrinol Metab; 2021 Nov; 65(1):3-13. PubMed ID: 33320454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obesity and COVID-19 : Mechanisms involved in the collusion of two pandemics].
    Favre L; Pantet O; Papadimitriou Olivgeris M
    Rev Med Suisse; 2021 Mar; 17(731):558-563. PubMed ID: 33760416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
    Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
    Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
    Suárez-Reyes A; Villegas-Valverde CA
    MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity, inflammation and COVID-19: preventive interest of ketogenic diet?].
    Charlot A; Boumiza R; Roux M; Zoll J
    Biol Aujourdhui; 2021; 215(1-2):63-72. PubMed ID: 34397376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and ethnicity: A novel pathophysiological role for inflammation.
    Vepa A; Bae JP; Ahmed F; Pareek M; Khunti K
    Diabetes Metab Syndr; 2020; 14(5):1043-1051. PubMed ID: 32640416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When Pandemics Collide: the Interplay of Obesity and COVID-19.
    Mundi MS; Patel JJ; Mohamed Elfadil O; Patel J; Patel I; Nanda S; Hurt RT
    Curr Gastroenterol Rep; 2021 Nov; 23(12):26. PubMed ID: 34735631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
    Front Immunol; 2022; 13():832394. PubMed ID: 35464491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
    Giovinazzo G; Gerardi C; Uberti-Foppa C; Lopalco L
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and the role of chronic inflammation in patients with obesity.
    Chiappetta S; Sharma AM; Bottino V; Stier C
    Int J Obes (Lond); 2020 Aug; 44(8):1790-1792. PubMed ID: 32409680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and Hematological Response in COVID-19.
    Słomka A; Martucci G; Raffa GM; Malvindi PG; Żekanowska E; Lorusso R; Suwalski P; Kowalewski M
    Adv Exp Med Biol; 2021; 1352():73-86. PubMed ID: 35132595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Xu K; Wei Y; Giunta S; Zhou M; Xia S
    Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.